Global Top 4 Companies Accounted for 87% of total Newborn Screening for SMA and SCID market (Business Opportunities - Marketing & Sales)
AUNetAds > Business Opportunities > Marketing & Sales
Item ID 2413044 in Category: Business Opportunities - Marketing & Sales
Global Top 4 Companies Accounted for 87% of total Newborn Screening for SMA and SCID market | |
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth. Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections. Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy. The global key manufacturers of Newborn Screening for SMA and SCID include Perkinelmer, Thermo Fisher, etc. In 2022, the global top three players had a share approximately 87.0% in terms of revenue. For more information, please contact the following e-mail address: Email: global@qyresearch.com Website: https://www.qyresearch.com  | |
| Target State: All States Target City : All Cities Last Update : 17 May 2024 4:08 PM Number of Views: 86 | Item Owner : David Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
AUNetAds > Business Opportunities > Marketing & Sales
© 2024 AUNetAds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com | USAOnlineClassifieds.com
2024-11-22 (0.224 sec)